Elite Pharmaceuticals Inc (ELTP): Total Liabilities
$39.41M
As of 2026-03-31
$34.84M
As of 2026-06-30
+48.9%
3-year compound annual growth
+31.5%
5-year compound annual growth
+6.7%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $39.41M | -8.1% | 2026-06-29, Balance as of period end |
| 2025-03-31 | $42.87M | +64.4% | 2026-06-29, Balance as of period end |
| 2024-03-31 | $26.07M | +118.4% | 2025-06-30, Balance as of period end |
| 2023-03-31 | $11.94M | +20.2% | 2024-07-01, Balance as of period end |
| 2022-03-31 | $9.93M | -1.1% | 2023-06-29, Balance as of period end |
| 2021-03-31 | $10.04M | -29.8% | 2022-06-29, Balance as of period end |
| 2020-03-31 | $14.30M | +10.0% | 2021-06-14, Balance as of period end |
| 2019-03-31 | $13.01M | +4.8% | 2020-06-29, Balance as of period end |
| 2018-03-31 | $12.41M | +43.5% | 2019-06-21, Balance as of period end |
| 2017-03-31 | $8.65M | -57.8% | 2018-06-14, Balance as of period end |
| 2016-03-31 | $20.51M | -20.0% | 2017-06-14, Balance as of period end |
| 2015-03-31 | $25.65M | -75.7% | 2016-06-15, Balance as of period end |
| 2014-03-31 | $105.52M | +432.9% | 2015-06-15, Balance as of period end |
| 2013-03-31 | $19.80M | -21.7% | 2014-06-30, Balance as of period end |
| 2012-03-31 | $25.30M | -14.7% | 2013-06-21, Balance as of period end |
| 2011-03-31 | $29.66M | n/a | 2012-06-29, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $39.41M | -8.1% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $201.25M | +38.2% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $401.34M | +14.5% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $241.54M | -9.5% |
| Liquidia Corp (LQDA) | 2025-12-31 | $283.19M | +87.6% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $191.91M | -4.1% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $465.08M | +6.5% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $697.32M | +10.4% |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $262.35M | -13.0% |
Compare ELTP, MGNX, KPTI, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗